Neon drop · Free ship $75+ · Enter the grid
Signal · Product Feed

LXS196 - CAS# 1874276-76-2 60100 GSK269962A exhibits more than 30-fold

SKU: 1026266094

4.8
PLN86.00 PLN108.00

Pay in 4 interest-free payments of $21.50 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Nov 24 - Nov 29

Live Spec

LXS196 - CAS# 1874276-76-2 60100 GSK269962A exhibits more than 30-foldLXS196, CAS No. 1874276 76 2, is a potent and orally active protein kinase C inhibitor for the treatment of uveal melanoma. Upon oral administration, protein kinase C inhibitor LXS196 binds to and inhibits PKC, which prevents the activation of PKC mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells. PKC, a serine threonine protein kinase overexpressed in certain types of cancer

Store: ecoilumi.com.br · Domain: ecoilumi.com.br

Description

GSK269962A exhibits more than 30-fold selectivity against a panel of serine/threonine kinases

identified by a high-throughput screening

InChiKey: VAVXGGRQQJZYBL-UHFFFAOYSA-N

PubMed Central PMCID: PMC4226443

AHU-377 hemicalcium salt

LXS196 - CAS# 1874276-76-2 60100 GSK269962A exhibits more than 30-foldLXS196, CAS No. 1874276 76 2, is a potent and orally active protein kinase C inhibitor for the treatment of uveal melanoma. Upon oral administration, protein kinase C inhibitor LXS196 binds to and inhibits PKC, which prevents the activation of PKC mediated signaling pathways. This may lead to the induction of cell cycle arrest and apoptosis in susceptible tumor cells. PKC, a serine threonine protein kinase overexpressed in certain types of cancer

Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products